Antibe Therapeutics sinks 4.5% as investors eye AGM February 28, 2017 17:00 EST
CANADIAN DAILY STOCK REPORT
Antibe Therapeutics Inc. (TSXV:ATE), Canada's 34th largest Biotechnology company by market cap, has sunk 1.0c (4.5%) from its last trading session of February 27 to close at 21.0c. Compared with the S&P/TSX 60 Index which fell 4.8 points (0.5%) in the day, the relative price change was -4.0%. The volume was 0.2 times the average daily trading volume of 159,738 shares.
UPCOMING EVENT: AGM
The annual general meeting (AGM) will be held on Tuesday, Marc...